Global Oral Factor Xa Inhibitors Supply, Demand and Key Producers, 2024-2030

Page: 142

Published Date: 16 Oct 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Oral Factor Xa inhibitors are a class of anticoagulant medications that prevent blood clot formation by directly blocking Factor Xa, an enzyme crucial to the clotting process. Taken orally, these drugs are used to manage and prevent conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF).Key examples include rivaroxaban, apixaban, and edoxaban.

The global Oral Factor Xa Inhibitors market size is expected to reach $ 32980 million by 2030, rising at a market growth of 5.9% CAGR during the forecast period (2024-2030).

The market for oral Factor Xa inhibitors has been expanding due to their advantages over traditional anticoagulants. Drugs such as rivaroxaban, apixaban, and edoxaban are increasingly favored for their ease of use, fixed dosing, and reduced need for monitoring, leading to their widespread adoption for managing conditions like deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF).

Innovation and competition are driving the market, with pharmaceutical companies focusing on developing new formulations and extended-release versions. These advancements aim to enhance efficacy, safety profiles, and patient convenience. The growing range of options is contributing to a more dynamic market, offering healthcare providers more choices for anticoagulant therapy.

Despite the growth, the market faces challenges such as high costs and the introduction of alternative therapies. Regulatory changes and evolving treatment guidelines can also impact market trends. However, ongoing research and development are likely to sustain market momentum, as new drug options and improved formulations continue to emerge.

This report studies the global Oral Factor Xa Inhibitors production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oral Factor Xa Inhibitors and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Factor Xa Inhibitors that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oral Factor Xa Inhibitors total production and demand, 2019-2030, (K Units)
Global Oral Factor Xa Inhibitors total production value, 2019-2030, (USD Million)
Global Oral Factor Xa Inhibitors production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Oral Factor Xa Inhibitors consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Oral Factor Xa Inhibitors domestic production, consumption, key domestic manufacturers and share
Global Oral Factor Xa Inhibitors production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Oral Factor Xa Inhibitors production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Oral Factor Xa Inhibitors production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Oral Factor Xa Inhibitors market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Bristol Myers Squibb, Daiichi Sankyo, Janssen Pharmaceuticals, Bayer, Mylan, Zydus, Lupin, Apotex, Accord Healthcare, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Factor Xa Inhibitors market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Oral Factor Xa Inhibitors Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oral Factor Xa Inhibitors Market, Segmentation by Type:
    Rivaroxaban
    Edoxaban
    Apixaban

Global Oral Factor Xa Inhibitors Market, Segmentation by Application:
    Deep Vein Thrombosis
    Pulmonary Embolism
    Atrial Fibrillation
    Other

Companies Profiled:
    Pfizer
    Bristol Myers Squibb
    Daiichi Sankyo
    Janssen Pharmaceuticals
    Bayer
    Mylan
    Zydus
    Lupin
    Apotex
    Accord Healthcare
    Chia Tai Tianqing Pharmaceutical
    Shanghai Huilun Pharmaceutical
    Qilu Pharmaceutical
    HEC Pharma
    Cspc Ouyi Pharmaceutical
    Zhejiang Hisun Pharmaceutical
    Hansoh Pharma
    Huahai Pharmaceutical
    Yangtze River Pharmaceutical

Key Questions Answered:
1. How big is the global Oral Factor Xa Inhibitors market?
2. What is the demand of the global Oral Factor Xa Inhibitors market?
3. What is the year over year growth of the global Oral Factor Xa Inhibitors market?
4. What is the production and production value of the global Oral Factor Xa Inhibitors market?
5. Who are the key producers in the global Oral Factor Xa Inhibitors market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Oral Factor Xa Inhibitors Introduction
    1.2 World Oral Factor Xa Inhibitors Supply & Forecast
        1.2.1 World Oral Factor Xa Inhibitors Production Value (2019 & 2023 & 2030)
        1.2.2 World Oral Factor Xa Inhibitors Production (2019-2030)
        1.2.3 World Oral Factor Xa Inhibitors Pricing Trends (2019-2030)
    1.3 World Oral Factor Xa Inhibitors Production by Region (Based on Production Site)
        1.3.1 World Oral Factor Xa Inhibitors Production Value by Region (2019-2030)
        1.3.2 World Oral Factor Xa Inhibitors Production by Region (2019-2030)
        1.3.3 World Oral Factor Xa Inhibitors Average Price by Region (2019-2030)
        1.3.4 North America Oral Factor Xa Inhibitors Production (2019-2030)
        1.3.5 Europe Oral Factor Xa Inhibitors Production (2019-2030)
        1.3.6 China Oral Factor Xa Inhibitors Production (2019-2030)
        1.3.7 Japan Oral Factor Xa Inhibitors Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oral Factor Xa Inhibitors Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oral Factor Xa Inhibitors Major Market Trends

2 Demand Summary
    2.1 World Oral Factor Xa Inhibitors Demand (2019-2030)
    2.2 World Oral Factor Xa Inhibitors Consumption by Region
        2.2.1 World Oral Factor Xa Inhibitors Consumption by Region (2019-2024)
        2.2.2 World Oral Factor Xa Inhibitors Consumption Forecast by Region (2025-2030)
    2.3 United States Oral Factor Xa Inhibitors Consumption (2019-2030)
    2.4 China Oral Factor Xa Inhibitors Consumption (2019-2030)
    2.5 Europe Oral Factor Xa Inhibitors Consumption (2019-2030)
    2.6 Japan Oral Factor Xa Inhibitors Consumption (2019-2030)
    2.7 South Korea Oral Factor Xa Inhibitors Consumption (2019-2030)
    2.8 ASEAN Oral Factor Xa Inhibitors Consumption (2019-2030)
    2.9 India Oral Factor Xa Inhibitors Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Oral Factor Xa Inhibitors Production Value by Manufacturer (2019-2024)
    3.2 World Oral Factor Xa Inhibitors Production by Manufacturer (2019-2024)
    3.3 World Oral Factor Xa Inhibitors Average Price by Manufacturer (2019-2024)
    3.4 Oral Factor Xa Inhibitors Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Oral Factor Xa Inhibitors Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Oral Factor Xa Inhibitors in 2023
        3.5.3 Global Concentration Ratios (CR8) for Oral Factor Xa Inhibitors in 2023
    3.6 Oral Factor Xa Inhibitors Market: Overall Company Footprint Analysis
        3.6.1 Oral Factor Xa Inhibitors Market: Region Footprint
        3.6.2 Oral Factor Xa Inhibitors Market: Company Product Type Footprint
        3.6.3 Oral Factor Xa Inhibitors Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Oral Factor Xa Inhibitors Production Value Comparison
        4.1.1 United States VS China: Oral Factor Xa Inhibitors Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Oral Factor Xa Inhibitors Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Oral Factor Xa Inhibitors Production Comparison
        4.2.1 United States VS China: Oral Factor Xa Inhibitors Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Oral Factor Xa Inhibitors Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Oral Factor Xa Inhibitors Consumption Comparison
        4.3.1 United States VS China: Oral Factor Xa Inhibitors Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Oral Factor Xa Inhibitors Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Oral Factor Xa Inhibitors Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Oral Factor Xa Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Oral Factor Xa Inhibitors Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Oral Factor Xa Inhibitors Production (2019-2024)
    4.5 China Based Oral Factor Xa Inhibitors Manufacturers and Market Share
        4.5.1 China Based Oral Factor Xa Inhibitors Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Oral Factor Xa Inhibitors Production Value (2019-2024)
        4.5.3 China Based Manufacturers Oral Factor Xa Inhibitors Production (2019-2024)
    4.6 Rest of World Based Oral Factor Xa Inhibitors Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Oral Factor Xa Inhibitors Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Oral Factor Xa Inhibitors Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Oral Factor Xa Inhibitors Production (2019-2024)

5 Market Analysis by Type
    5.1 World Oral Factor Xa Inhibitors Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Rivaroxaban
        5.2.2 Edoxaban
        5.2.3 Apixaban
    5.3 Market Segment by Type
        5.3.1 World Oral Factor Xa Inhibitors Production by Type (2019-2030)
        5.3.2 World Oral Factor Xa Inhibitors Production Value by Type (2019-2030)
        5.3.3 World Oral Factor Xa Inhibitors Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Oral Factor Xa Inhibitors Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Deep Vein Thrombosis
        6.2.2 Pulmonary Embolism
        6.2.3 Atrial Fibrillation
        6.2.4 Other
    6.3 Market Segment by Application
        6.3.1 World Oral Factor Xa Inhibitors Production by Application (2019-2030)
        6.3.2 World Oral Factor Xa Inhibitors Production Value by Application (2019-2030)
        6.3.3 World Oral Factor Xa Inhibitors Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Details
        7.1.2 Pfizer Major Business
        7.1.3 Pfizer Oral Factor Xa Inhibitors Product and Services
        7.1.4 Pfizer Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Pfizer Recent Developments/Updates
        7.1.6 Pfizer Competitive Strengths & Weaknesses
    7.2 Bristol Myers Squibb
        7.2.1 Bristol Myers Squibb Details
        7.2.2 Bristol Myers Squibb Major Business
        7.2.3 Bristol Myers Squibb Oral Factor Xa Inhibitors Product and Services
        7.2.4 Bristol Myers Squibb Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Bristol Myers Squibb Recent Developments/Updates
        7.2.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
    7.3 Daiichi Sankyo
        7.3.1 Daiichi Sankyo Details
        7.3.2 Daiichi Sankyo Major Business
        7.3.3 Daiichi Sankyo Oral Factor Xa Inhibitors Product and Services
        7.3.4 Daiichi Sankyo Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Daiichi Sankyo Recent Developments/Updates
        7.3.6 Daiichi Sankyo Competitive Strengths & Weaknesses
    7.4 Janssen Pharmaceuticals
        7.4.1 Janssen Pharmaceuticals Details
        7.4.2 Janssen Pharmaceuticals Major Business
        7.4.3 Janssen Pharmaceuticals Oral Factor Xa Inhibitors Product and Services
        7.4.4 Janssen Pharmaceuticals Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Janssen Pharmaceuticals Recent Developments/Updates
        7.4.6 Janssen Pharmaceuticals Competitive Strengths & Weaknesses
    7.5 Bayer
        7.5.1 Bayer Details
        7.5.2 Bayer Major Business
        7.5.3 Bayer Oral Factor Xa Inhibitors Product and Services
        7.5.4 Bayer Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Bayer Recent Developments/Updates
        7.5.6 Bayer Competitive Strengths & Weaknesses
    7.6 Mylan
        7.6.1 Mylan Details
        7.6.2 Mylan Major Business
        7.6.3 Mylan Oral Factor Xa Inhibitors Product and Services
        7.6.4 Mylan Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Mylan Recent Developments/Updates
        7.6.6 Mylan Competitive Strengths & Weaknesses
    7.7 Zydus
        7.7.1 Zydus Details
        7.7.2 Zydus Major Business
        7.7.3 Zydus Oral Factor Xa Inhibitors Product and Services
        7.7.4 Zydus Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Zydus Recent Developments/Updates
        7.7.6 Zydus Competitive Strengths & Weaknesses
    7.8 Lupin
        7.8.1 Lupin Details
        7.8.2 Lupin Major Business
        7.8.3 Lupin Oral Factor Xa Inhibitors Product and Services
        7.8.4 Lupin Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Lupin Recent Developments/Updates
        7.8.6 Lupin Competitive Strengths & Weaknesses
    7.9 Apotex
        7.9.1 Apotex Details
        7.9.2 Apotex Major Business
        7.9.3 Apotex Oral Factor Xa Inhibitors Product and Services
        7.9.4 Apotex Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Apotex Recent Developments/Updates
        7.9.6 Apotex Competitive Strengths & Weaknesses
    7.10 Accord Healthcare
        7.10.1 Accord Healthcare Details
        7.10.2 Accord Healthcare Major Business
        7.10.3 Accord Healthcare Oral Factor Xa Inhibitors Product and Services
        7.10.4 Accord Healthcare Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Accord Healthcare Recent Developments/Updates
        7.10.6 Accord Healthcare Competitive Strengths & Weaknesses
    7.11 Chia Tai Tianqing Pharmaceutical
        7.11.1 Chia Tai Tianqing Pharmaceutical Details
        7.11.2 Chia Tai Tianqing Pharmaceutical Major Business
        7.11.3 Chia Tai Tianqing Pharmaceutical Oral Factor Xa Inhibitors Product and Services
        7.11.4 Chia Tai Tianqing Pharmaceutical Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
        7.11.6 Chia Tai Tianqing Pharmaceutical Competitive Strengths & Weaknesses
    7.12 Shanghai Huilun Pharmaceutical
        7.12.1 Shanghai Huilun Pharmaceutical Details
        7.12.2 Shanghai Huilun Pharmaceutical Major Business
        7.12.3 Shanghai Huilun Pharmaceutical Oral Factor Xa Inhibitors Product and Services
        7.12.4 Shanghai Huilun Pharmaceutical Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Shanghai Huilun Pharmaceutical Recent Developments/Updates
        7.12.6 Shanghai Huilun Pharmaceutical Competitive Strengths & Weaknesses
    7.13 Qilu Pharmaceutical
        7.13.1 Qilu Pharmaceutical Details
        7.13.2 Qilu Pharmaceutical Major Business
        7.13.3 Qilu Pharmaceutical Oral Factor Xa Inhibitors Product and Services
        7.13.4 Qilu Pharmaceutical Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Qilu Pharmaceutical Recent Developments/Updates
        7.13.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
    7.14 HEC Pharma
        7.14.1 HEC Pharma Details
        7.14.2 HEC Pharma Major Business
        7.14.3 HEC Pharma Oral Factor Xa Inhibitors Product and Services
        7.14.4 HEC Pharma Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 HEC Pharma Recent Developments/Updates
        7.14.6 HEC Pharma Competitive Strengths & Weaknesses
    7.15 Cspc Ouyi Pharmaceutical
        7.15.1 Cspc Ouyi Pharmaceutical Details
        7.15.2 Cspc Ouyi Pharmaceutical Major Business
        7.15.3 Cspc Ouyi Pharmaceutical Oral Factor Xa Inhibitors Product and Services
        7.15.4 Cspc Ouyi Pharmaceutical Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 Cspc Ouyi Pharmaceutical Recent Developments/Updates
        7.15.6 Cspc Ouyi Pharmaceutical Competitive Strengths & Weaknesses
    7.16 Zhejiang Hisun Pharmaceutical
        7.16.1 Zhejiang Hisun Pharmaceutical Details
        7.16.2 Zhejiang Hisun Pharmaceutical Major Business
        7.16.3 Zhejiang Hisun Pharmaceutical Oral Factor Xa Inhibitors Product and Services
        7.16.4 Zhejiang Hisun Pharmaceutical Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.16.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
        7.16.6 Zhejiang Hisun Pharmaceutical Competitive Strengths & Weaknesses
    7.17 Hansoh Pharma
        7.17.1 Hansoh Pharma Details
        7.17.2 Hansoh Pharma Major Business
        7.17.3 Hansoh Pharma Oral Factor Xa Inhibitors Product and Services
        7.17.4 Hansoh Pharma Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.17.5 Hansoh Pharma Recent Developments/Updates
        7.17.6 Hansoh Pharma Competitive Strengths & Weaknesses
    7.18 Huahai Pharmaceutical
        7.18.1 Huahai Pharmaceutical Details
        7.18.2 Huahai Pharmaceutical Major Business
        7.18.3 Huahai Pharmaceutical Oral Factor Xa Inhibitors Product and Services
        7.18.4 Huahai Pharmaceutical Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.18.5 Huahai Pharmaceutical Recent Developments/Updates
        7.18.6 Huahai Pharmaceutical Competitive Strengths & Weaknesses
    7.19 Yangtze River Pharmaceutical
        7.19.1 Yangtze River Pharmaceutical Details
        7.19.2 Yangtze River Pharmaceutical Major Business
        7.19.3 Yangtze River Pharmaceutical Oral Factor Xa Inhibitors Product and Services
        7.19.4 Yangtze River Pharmaceutical Oral Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.19.5 Yangtze River Pharmaceutical Recent Developments/Updates
        7.19.6 Yangtze River Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oral Factor Xa Inhibitors Industry Chain
    8.2 Oral Factor Xa Inhibitors Upstream Analysis
        8.2.1 Oral Factor Xa Inhibitors Core Raw Materials
        8.2.2 Main Manufacturers of Oral Factor Xa Inhibitors Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Oral Factor Xa Inhibitors Production Mode
    8.6 Oral Factor Xa Inhibitors Procurement Model
    8.7 Oral Factor Xa Inhibitors Industry Sales Model and Sales Channels
        8.7.1 Oral Factor Xa Inhibitors Sales Model
        8.7.2 Oral Factor Xa Inhibitors Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Oral Factor Xa Inhibitors Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Oral Factor Xa Inhibitors Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Oral Factor Xa Inhibitors Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Oral Factor Xa Inhibitors Production Value Market Share by Region (2019-2024)
 Table 5. World Oral Factor Xa Inhibitors Production Value Market Share by Region (2025-2030)
 Table 6. World Oral Factor Xa Inhibitors Production by Region (2019-2024) & (K Units)
 Table 7. World Oral Factor Xa Inhibitors Production by Region (2025-2030) & (K Units)
 Table 8. World Oral Factor Xa Inhibitors Production Market Share by Region (2019-2024)
 Table 9. World Oral Factor Xa Inhibitors Production Market Share by Region (2025-2030)
 Table 10. World Oral Factor Xa Inhibitors Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Oral Factor Xa Inhibitors Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Oral Factor Xa Inhibitors Major Market Trends
 Table 13. World Oral Factor Xa Inhibitors Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Oral Factor Xa Inhibitors Consumption by Region (2019-2024) & (K Units)
 Table 15. World Oral Factor Xa Inhibitors Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Oral Factor Xa Inhibitors Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Oral Factor Xa Inhibitors Producers in 2023
 Table 18. World Oral Factor Xa Inhibitors Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Oral Factor Xa Inhibitors Producers in 2023
 Table 20. World Oral Factor Xa Inhibitors Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Oral Factor Xa Inhibitors Company Evaluation Quadrant
 Table 22. World Oral Factor Xa Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Oral Factor Xa Inhibitors Production Site of Key Manufacturer
 Table 24. Oral Factor Xa Inhibitors Market: Company Product Type Footprint
 Table 25. Oral Factor Xa Inhibitors Market: Company Product Application Footprint
 Table 26. Oral Factor Xa Inhibitors Competitive Factors
 Table 27. Oral Factor Xa Inhibitors New Entrant and Capacity Expansion Plans
 Table 28. Oral Factor Xa Inhibitors Mergers & Acquisitions Activity
 Table 29. United States VS China Oral Factor Xa Inhibitors Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Oral Factor Xa Inhibitors Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Oral Factor Xa Inhibitors Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Oral Factor Xa Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Oral Factor Xa Inhibitors Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Oral Factor Xa Inhibitors Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Oral Factor Xa Inhibitors Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Oral Factor Xa Inhibitors Production Market Share (2019-2024)
 Table 37. China Based Oral Factor Xa Inhibitors Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Oral Factor Xa Inhibitors Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Oral Factor Xa Inhibitors Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Oral Factor Xa Inhibitors Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Oral Factor Xa Inhibitors Production Market Share (2019-2024)
 Table 42. Rest of World Based Oral Factor Xa Inhibitors Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Oral Factor Xa Inhibitors Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Oral Factor Xa Inhibitors Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Oral Factor Xa Inhibitors Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Oral Factor Xa Inhibitors Production Market Share (2019-2024)
 Table 47. World Oral Factor Xa Inhibitors Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Oral Factor Xa Inhibitors Production by Type (2019-2024) & (K Units)
 Table 49. World Oral Factor Xa Inhibitors Production by Type (2025-2030) & (K Units)
 Table 50. World Oral Factor Xa Inhibitors Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Oral Factor Xa Inhibitors Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Oral Factor Xa Inhibitors Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Oral Factor Xa Inhibitors Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Oral Factor Xa Inhibitors Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Oral Factor Xa Inhibitors Production by Application (2019-2024) & (K Units)
 Table 56. World Oral Factor Xa Inhibitors Production by Application (2025-2030) & (K Units)
 Table 57. World Oral Factor Xa Inhibitors Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Oral Factor Xa Inhibitors Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Oral Factor Xa Inhibitors Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Oral Factor Xa Inhibitors Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
 Table 62. Pfizer Major Business
 Table 63. Pfizer Oral Factor Xa Inhibitors Product and Services
 Table 64. Pfizer Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Pfizer Recent Developments/Updates
 Table 66. Pfizer Competitive Strengths & Weaknesses
 Table 67. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
 Table 68. Bristol Myers Squibb Major Business
 Table 69. Bristol Myers Squibb Oral Factor Xa Inhibitors Product and Services
 Table 70. Bristol Myers Squibb Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Bristol Myers Squibb Recent Developments/Updates
 Table 72. Bristol Myers Squibb Competitive Strengths & Weaknesses
 Table 73. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
 Table 74. Daiichi Sankyo Major Business
 Table 75. Daiichi Sankyo Oral Factor Xa Inhibitors Product and Services
 Table 76. Daiichi Sankyo Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Daiichi Sankyo Recent Developments/Updates
 Table 78. Daiichi Sankyo Competitive Strengths & Weaknesses
 Table 79. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 80. Janssen Pharmaceuticals Major Business
 Table 81. Janssen Pharmaceuticals Oral Factor Xa Inhibitors Product and Services
 Table 82. Janssen Pharmaceuticals Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Janssen Pharmaceuticals Recent Developments/Updates
 Table 84. Janssen Pharmaceuticals Competitive Strengths & Weaknesses
 Table 85. Bayer Basic Information, Manufacturing Base and Competitors
 Table 86. Bayer Major Business
 Table 87. Bayer Oral Factor Xa Inhibitors Product and Services
 Table 88. Bayer Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Bayer Recent Developments/Updates
 Table 90. Bayer Competitive Strengths & Weaknesses
 Table 91. Mylan Basic Information, Manufacturing Base and Competitors
 Table 92. Mylan Major Business
 Table 93. Mylan Oral Factor Xa Inhibitors Product and Services
 Table 94. Mylan Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Mylan Recent Developments/Updates
 Table 96. Mylan Competitive Strengths & Weaknesses
 Table 97. Zydus Basic Information, Manufacturing Base and Competitors
 Table 98. Zydus Major Business
 Table 99. Zydus Oral Factor Xa Inhibitors Product and Services
 Table 100. Zydus Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Zydus Recent Developments/Updates
 Table 102. Zydus Competitive Strengths & Weaknesses
 Table 103. Lupin Basic Information, Manufacturing Base and Competitors
 Table 104. Lupin Major Business
 Table 105. Lupin Oral Factor Xa Inhibitors Product and Services
 Table 106. Lupin Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. Lupin Recent Developments/Updates
 Table 108. Lupin Competitive Strengths & Weaknesses
 Table 109. Apotex Basic Information, Manufacturing Base and Competitors
 Table 110. Apotex Major Business
 Table 111. Apotex Oral Factor Xa Inhibitors Product and Services
 Table 112. Apotex Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Apotex Recent Developments/Updates
 Table 114. Apotex Competitive Strengths & Weaknesses
 Table 115. Accord Healthcare Basic Information, Manufacturing Base and Competitors
 Table 116. Accord Healthcare Major Business
 Table 117. Accord Healthcare Oral Factor Xa Inhibitors Product and Services
 Table 118. Accord Healthcare Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Accord Healthcare Recent Developments/Updates
 Table 120. Accord Healthcare Competitive Strengths & Weaknesses
 Table 121. Chia Tai Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 122. Chia Tai Tianqing Pharmaceutical Major Business
 Table 123. Chia Tai Tianqing Pharmaceutical Oral Factor Xa Inhibitors Product and Services
 Table 124. Chia Tai Tianqing Pharmaceutical Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
 Table 126. Chia Tai Tianqing Pharmaceutical Competitive Strengths & Weaknesses
 Table 127. Shanghai Huilun Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 128. Shanghai Huilun Pharmaceutical Major Business
 Table 129. Shanghai Huilun Pharmaceutical Oral Factor Xa Inhibitors Product and Services
 Table 130. Shanghai Huilun Pharmaceutical Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Shanghai Huilun Pharmaceutical Recent Developments/Updates
 Table 132. Shanghai Huilun Pharmaceutical Competitive Strengths & Weaknesses
 Table 133. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 134. Qilu Pharmaceutical Major Business
 Table 135. Qilu Pharmaceutical Oral Factor Xa Inhibitors Product and Services
 Table 136. Qilu Pharmaceutical Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. Qilu Pharmaceutical Recent Developments/Updates
 Table 138. Qilu Pharmaceutical Competitive Strengths & Weaknesses
 Table 139. HEC Pharma Basic Information, Manufacturing Base and Competitors
 Table 140. HEC Pharma Major Business
 Table 141. HEC Pharma Oral Factor Xa Inhibitors Product and Services
 Table 142. HEC Pharma Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 143. HEC Pharma Recent Developments/Updates
 Table 144. HEC Pharma Competitive Strengths & Weaknesses
 Table 145. Cspc Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 146. Cspc Ouyi Pharmaceutical Major Business
 Table 147. Cspc Ouyi Pharmaceutical Oral Factor Xa Inhibitors Product and Services
 Table 148. Cspc Ouyi Pharmaceutical Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 149. Cspc Ouyi Pharmaceutical Recent Developments/Updates
 Table 150. Cspc Ouyi Pharmaceutical Competitive Strengths & Weaknesses
 Table 151. Zhejiang Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 152. Zhejiang Hisun Pharmaceutical Major Business
 Table 153. Zhejiang Hisun Pharmaceutical Oral Factor Xa Inhibitors Product and Services
 Table 154. Zhejiang Hisun Pharmaceutical Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 155. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
 Table 156. Zhejiang Hisun Pharmaceutical Competitive Strengths & Weaknesses
 Table 157. Hansoh Pharma Basic Information, Manufacturing Base and Competitors
 Table 158. Hansoh Pharma Major Business
 Table 159. Hansoh Pharma Oral Factor Xa Inhibitors Product and Services
 Table 160. Hansoh Pharma Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 161. Hansoh Pharma Recent Developments/Updates
 Table 162. Hansoh Pharma Competitive Strengths & Weaknesses
 Table 163. Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 164. Huahai Pharmaceutical Major Business
 Table 165. Huahai Pharmaceutical Oral Factor Xa Inhibitors Product and Services
 Table 166. Huahai Pharmaceutical Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 167. Huahai Pharmaceutical Recent Developments/Updates
 Table 168. Huahai Pharmaceutical Competitive Strengths & Weaknesses
 Table 169. Yangtze River Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 170. Yangtze River Pharmaceutical Major Business
 Table 171. Yangtze River Pharmaceutical Oral Factor Xa Inhibitors Product and Services
 Table 172. Yangtze River Pharmaceutical Oral Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 173. Yangtze River Pharmaceutical Recent Developments/Updates
 Table 174. Yangtze River Pharmaceutical Competitive Strengths & Weaknesses
 Table 175. Global Key Players of Oral Factor Xa Inhibitors Upstream (Raw Materials)
 Table 176. Global Oral Factor Xa Inhibitors Typical Customers
 Table 177. Oral Factor Xa Inhibitors Typical Distributors


List of Figures
 Figure 1. Oral Factor Xa Inhibitors Picture
 Figure 2. World Oral Factor Xa Inhibitors Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Oral Factor Xa Inhibitors Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Oral Factor Xa Inhibitors Production (2019-2030) & (K Units)
 Figure 5. World Oral Factor Xa Inhibitors Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Oral Factor Xa Inhibitors Production Value Market Share by Region (2019-2030)
 Figure 7. World Oral Factor Xa Inhibitors Production Market Share by Region (2019-2030)
 Figure 8. North America Oral Factor Xa Inhibitors Production (2019-2030) & (K Units)
 Figure 9. Europe Oral Factor Xa Inhibitors Production (2019-2030) & (K Units)
 Figure 10. China Oral Factor Xa Inhibitors Production (2019-2030) & (K Units)
 Figure 11. Japan Oral Factor Xa Inhibitors Production (2019-2030) & (K Units)
 Figure 12. Oral Factor Xa Inhibitors Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Oral Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 15. World Oral Factor Xa Inhibitors Consumption Market Share by Region (2019-2030)
 Figure 16. United States Oral Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 17. China Oral Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 18. Europe Oral Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 19. Japan Oral Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Oral Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Oral Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 22. India Oral Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Oral Factor Xa Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Oral Factor Xa Inhibitors Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Oral Factor Xa Inhibitors Markets in 2023
 Figure 26. United States VS China: Oral Factor Xa Inhibitors Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Oral Factor Xa Inhibitors Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Oral Factor Xa Inhibitors Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Oral Factor Xa Inhibitors Production Market Share 2023
 Figure 30. China Based Manufacturers Oral Factor Xa Inhibitors Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Oral Factor Xa Inhibitors Production Market Share 2023
 Figure 32. World Oral Factor Xa Inhibitors Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Oral Factor Xa Inhibitors Production Value Market Share by Type in 2023
 Figure 34. Rivaroxaban
 Figure 35. Edoxaban
 Figure 36. Apixaban
 Figure 37. World Oral Factor Xa Inhibitors Production Market Share by Type (2019-2030)
 Figure 38. World Oral Factor Xa Inhibitors Production Value Market Share by Type (2019-2030)
 Figure 39. World Oral Factor Xa Inhibitors Average Price by Type (2019-2030) & (US$/Unit)
 Figure 40. World Oral Factor Xa Inhibitors Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 41. World Oral Factor Xa Inhibitors Production Value Market Share by Application in 2023
 Figure 42. Deep Vein Thrombosis
 Figure 43. Pulmonary Embolism
 Figure 44. Atrial Fibrillation
 Figure 45. Other
 Figure 46. World Oral Factor Xa Inhibitors Production Market Share by Application (2019-2030)
 Figure 47. World Oral Factor Xa Inhibitors Production Value Market Share by Application (2019-2030)
 Figure 48. World Oral Factor Xa Inhibitors Average Price by Application (2019-2030) & (US$/Unit)
 Figure 49. Oral Factor Xa Inhibitors Industry Chain
 Figure 50. Oral Factor Xa Inhibitors Procurement Model
 Figure 51. Oral Factor Xa Inhibitors Sales Model
 Figure 52. Oral Factor Xa Inhibitors Sales Channels, Direct Sales, and Distribution
 Figure 53. Methodology
 Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer
Bristol Myers Squibb
Daiichi Sankyo
Janssen Pharmaceuticals
Bayer
Mylan
Zydus
Lupin
Apotex
Accord Healthcare
Chia Tai Tianqing Pharmaceutical
Shanghai Huilun Pharmaceutical
Qilu Pharmaceutical
HEC Pharma
Cspc Ouyi Pharmaceutical
Zhejiang Hisun Pharmaceutical
Hansoh Pharma
Huahai Pharmaceutical
Yangtze River Pharmaceutical

Related Reports

Global Oral Factor Xa Inhibitors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Oral Factor Xa Inhibitors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 16 Oct 2024

date Pharma & Healthcare

Oral Factor Xa inhibitors are a class of anticoagulant medications that prevent blood clot formation by directly blocking Factor Xa, an enzyme crucial to the clotting process. Taken orally, these drugs are used to manage and prevent conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF).Key examples include rivaroxaban, apixaban, and edoxaban.

Product Tags

Oral Factor Xa Inhibitors

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>